Visiopharm

Visiopharm is a Denmark-based provider of AI-driven precision pathology software. Founded in 2002, the company's mission is to advance precision medicine by transforming pathology through image analysis. Visiopharm provides tools for scientists, pathologists, and image analysis experts to produce accurate data for tissue-based research. In diagnostics, it specializes in clinical applications with nine diagnostic algorithms cleared under IVDR for EU customers, offering decision support and integration into existing lab workflows. Visiopharm operates internationally with over 750 customer accounts in more than 40 countries. It was acquired by Grundium in 2023.